Dermatan sulfate as a potential antithrombotic drug
Pangrazzi, J.; Gianese, F.
Haematologica 72(5): 459-464
1987
ISSN/ISBN: 0390-6078 PMID: 3121470 Document Number: 293668
Document emailed within 1 workday
Related Documents
Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1991: Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin Seminars in Thrombosis and Hemostasis 17(Suppl 1): 60-64Maniscalco, W.M.; Campbell, M.H. 1994: Transforming growth factor-beta induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells American Journal of Physiology 266(6 Pt 1): L672-L680
Thomas, D.P.; Gray, E.; Merton, R.E. 1990: Potentiation of the antithrombotic action of dermatan sulphate by small amounts of heparin Thrombosis and Haemostasis 64(2): 290-293
Ryan, K.E.; Lane, D.A.; Flynn, A.; Ireland, H.; Boisclair, M.; Shepperd, J.; Curtis, J.R. 1992: Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure Thrombosis and Haemostasis 68(5): 563-569
Gianese, F.; Lucchelli, P.E. 1991: A survey of the clinical experience with dermatan sulfate Seminars in Thrombosis and Hemostasis 17(Suppl 2): 199-204
Fan, H.Z.; Liu, Y.X.; Xie, K.Q.; Zhang, A. 1994: Characterization and quantification of dermatan sulfate from donkey skin Zhongguo Zhong Yao Za Zhi 19(8): 477-480; 511
Vitale, C.; Verdecchia, C.; Bagnis, C.; Ganzaroli, M.; Giorcelli, G.; Marangella, M. 2008: Effects of dermatan sulfate for anticoagulation in continuous renal replacement therapy Journal of Nephrology 21(2): 205-212
Blardi, P.; Messa, G.L.; Urso, R.; Di Perri, T. 1993: Pharmacokinetics and pharmacodynamics of dermatan sulfate after intravenous and intramuscular administration to healthy volunteers International Journal of Clinical Pharmacology Research 13(4): 231-238
Bazzoni, G.; Beltrán Nuñez, A.; Mascellani, G.; Bianchini, P.; Dejana, E.; Del Maschio, A. 1993: Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions Journal of Laboratory and Clinical Medicine 121(2): 268-275
Di Carlo, V.; Agnelli, G.; Prandoni, P.; Coccheri, S.; Gensini, G.F.; Gianese, F.; Mannucci, P.M. 1999: Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group Thrombosis and Haemostasis 82(1): 30-34
DiMinno, G.; Silver, M.J. 1983: Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol Journal of Pharmacology and Experimental Therapeutics 225(1): 57-60
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Pinhal, M.A.; Santos, I.A.; Silva, I.F.; Dietrich, C.P.; Nader, H.B. 1995: Minimum fragments of the heparin molecule able to produce the accumulation and change of the sulfation pattern of an antithrombotic heparan sulfate from endothelial cells Thrombosis and Haemostasis 74(4): 1169-1174
Nishizawa, E.E.; Mendoza, A.R.; Honohan, T.; Annis, K.A. 1982: A thiazole compound with potential antithrombotic activity Thrombosis and Haemostasis 47(2): 173-176
Ivaldi, M.; Mazzilli, F.; Santoro, S.; Crescenzi, F.; Santoro, C. 1979: Study of a drug combination for topical use, with contraceptive, antibacterial and antimycotic action and venereal disease preventive action. II. Optical microscopic and scanning microscopic studies of morphological changes of human spermatozoa in vitro after contact with the oxyquinoline sulfate and copper sulfate association Minerva Ginecologica 31(5): 387-390
Stiefehlhagen, P. 2013: Your patient needs an antithrombotic drug, 4: Recurrence prevention after thrombosis: how long and with what? MMW Fortschritte der Medizin 155 Spec no 1(1): 28
Gallo, R.L.; Bucay, V.W.; Shamban, A.T.; Lima-Maribona, J.; Lewis, A.B.; Ditre, C.M.; Mayoral, F.A.; Gold, M.H. 2015: The Potential Role of Topically Applied Heparan Sulfate in the Treatment of Photodamage Journal of Drugs in Dermatology: Jdd 14(7): 669-674
Moyer, J.A.; Shah, J.; Nowakowski, K.; Martin, A.; McNicholas, A.; Muller, A.; Fernandez, F.B.; Ong, A.W. 2018: Does Antithrombotic Drug use Mandate Trauma Team Activation in Awake Geriatric Patients with Intracranial Hemorrhage? American Surgeon 84(7): 1180-1184
Tománková, H. 1970: Determination of (2-(octahydro-1'-azocinyl)ethyl) guanidine sulfate (guanethidine sulfate) in non-aqueous mdium. Thin layer chromatography of guanethidine sulfate Ceskoslovenska Farmacie 19(3): 96-98
Yan, J.; Liu, L.; Li, X.; Wang, F.; Zhu, T.; Yuan, P.; Zhang, Q. 2006: A potential use of collagen-hyaluronan-chondroitin sulfate tri-copolymer scaffold for cartilage tissue engineering Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 20(2): 130-133